Cambridge, MA and Osaka, Japan - Harvard University's Office of Technology Development (OTD) and DAISO Co., LTD., Fine Chemicals Division, have signed a licensing agreement aimed at addressing one of the most difficult problems facing pharmaceutical development; ensuring the proper molecular conformation, or "chirality," of manufactured drugs.
